A global view of pulmonary hypertension. (Q38774437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

A global view of pulmonary hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marc Humbert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rogério Souza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

5

Steven M Kawut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

7

Zhi-Cheng Jing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Majdy Idrees

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Karen Sliwa-Hahnle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

J Simon R Gibbs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

12 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

306-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

Definitions and diagnosis of pulmonary hypertension.

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Relevant issues in the pathology and pathobiology of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

A USA-based registry for pulmonary arterial hypertension: 1982-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

New predictors of outcome in idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

An epidemiological study of pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension in France: results from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension: epidemiology and registries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in pulmonary hypertension in Spain: insights from the Spanish registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in an incident cohort of patients with pulmonary arterial hypertension in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence and prevalence of pulmonary arterial hypertension in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Genetics and genomics of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Sex and haemodynamics in pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence of portopulmonary hypertension among liver transplant candidates in a region highly endemic for viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Portopulmonary hypertension: Results from a 10-year screening algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Clinical risk factors for portopulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Mortality in adult congenital heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

1 reference

7 January 2021

The global status of schistosomiasis and its control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Human schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Cardiopulmonary manifestations of hepatosplenic schistosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Schistosomiasis-associated pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in schistosomiasis-associated pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Primary pulmonary hypertension in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Systolic and diastolic heart failure in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic importance of pulmonary hypertension in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology and risk profile of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Trends in Heart Failure Incidence and Survival in a Community-Based Population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary pressures and death in heart failure: a community study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: implications for transcatheter aortic valve replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Patients With Severe Symptomatic Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: Insights From the New Proposed Pulmonary Hypertension Classi

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Right ventricular function in heart failure with preserved ejection fraction: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology of heart failure in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Hypertensive heart failure in Nigerian Africans: insights from the Abeokuta Heart Failure Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Heart failure in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology of heart failure in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The evolving epidemiology of valvular aortic stenosis. the Tromsø study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Trends in aortic valve replacement for elderly patients in the United States, 1999-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The global burden of group A streptococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Rheumatic heart disease in rural south India: A clinico-observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Management of valvular disease in pregnancy: a global perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Chronic obstructive pulmonary disease: current burden and future projections.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

An estimate of the prevalence of COPD in Africa: a systematic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

COPD prevalence in 12 Asia–Pacific countries and regions: Projections based on the COPD prevalence estimation model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Global burden of COPD: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Hemodynamic characterization of patients with severe emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Impact of pulmonary artery pressure on exercise function in severe COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Clinical characteristics and prediction of pulmonary hypertension in severe emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Categorization and impact of pulmonary hypertension in patients with advanced COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Right and left ventricular dysfunction in patients with severe pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Severe pulmonary hypertension and chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Idiopathic pulmonary fibrosis--results from a Japanese nationwide epidemiological survey using individual clinical records

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in Saudi Arabia: A single center experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Human adaptation to high altitude: regional and life-cycle perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Subacute infantile mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

High-altitude disorders: pulmonary hypertension: pulmonary vascular disease: the global perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in patients with chronic and end-stage kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Severe Pulmonary Hypertension in Histiocytosis X

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Echocardiographic assessment of pulmonary hypertension in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Sickle cell in Latin America and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Epidemiology of haemoglobin disorders in Europe: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

A hemodynamic study of pulmonary hypertension in sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Hemodynamic predictors of mortality in adults with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Mortality in adults with sickle cell disease and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Pulmonary hypertension in well-transfused thalassemia major patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Cardiac status in well-treated patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Prevalence of pulmonary hypertension in hereditary spherocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Splenectomy and chronic thromboembolic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

The lifetime risk of developing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900543-3

7 January 2021

10.1016/S2213-2600(15)00543-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26975810%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference